Stifel analyst Jonathan Block maintains Align Tech (NASDAQ:ALGN) with a Buy and raises the price target from $265 to $375.
Expert Ratings for C4 Therapeutics
C4 Therapeutics (NASDAQ:CCCC) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…